"It’s a privilege to work with visionary entrepreneurs who are creating the technologies and procedures that define the future of medical care. And it’s exciting to help them craft business strategies that propel and transform their ideas into market penetration and real-world success."
Gil's Latest Buzz
Dr. Gil Kliman joined InterWest's healthcare team in 1996. He invests in a broad array of healthcare opportunities with a special interest in ophthalmology, medical devices, and healthcare IT. He is a board member of Autonomic Technologies, Benvenue, Doximity, Glaukos, Gobiquity, On Demand Therapeutics, Restoration Robotics, and ReVision Optics. He was an early investor in IntraLase and LenSx, two pioneering ophthalmic laser companies that led transformative advances in eye surgery around the world.
Prior to InterWest, Gil was a health care investor at TA Associates and at Norwest Venture Capital. A former practicing ophthalmologist and laser researcher, he was previously west coast director of LCA Vision, and served as an assistant professor at Tufts New England Eye Center and on the clinical faculty at Massachusetts Eye and Ear Infirmary.
Gil has a B.A. from Harvard University. He received an M.D. from the University of Pennsylvania and an M.B.A. from Stanford University. He completed an ophthalmology residency at Wills Eye Institute and retina fellowship at Massachusetts Eye and Ear Infirmary as a Heed Fellow. He also serves as a National Trustee for the Foundation Fighting Blindness.
Epocrates (Acquired by Athena Health in 2013), INC Research (Acquired by Avista Capital Partners in 2010), Inspire Pharmaceuticals (IPO 2000, ISPH) IntraLase (IPO 2004, ILSE), LenSx Lasers (Acquired by Alcon in 2010), Spinal Dynamics (Acquired by Medtronic in 2002), Spiration (Acquired by Olympus Medical Systems in 2010)
Over the last 20 years I have had the privilege of diverse life experiences as a laser researcher, practicing physician, startup company founder, and technology venture capitalist. I most enjoy being on the front edge of new technology waves, looking over the horizon for non-obvious opportunities... What I find exciting is working alongside visionary entrepreneurs, thinking non-traditionally, and helping to identify creative strategies to make pioneering ventures even more successful.